Skip to main content
Fig. 1 | Orphanet Journal of Rare Diseases

Fig. 1

From: Sirolimus reduces the risk of pneumothorax recurrence in patients with lymphangioleiomyomatosis: a historical prospective self-controlled study

Fig. 1

Initial presentation and the cumulative risk of pneumothorax in LAM. A Initial chief complaint of LAM patients. Ninety-eight (24.5%) patients had pneumothorax as the first symptom of LAM. Skin lesions refer to skin manifestations in patients with TSC-LAM. B In situations where pneumothorax was not the initial symptom of LAM, the cumulative risk of pneumothorax at 5, 10, and 20 years after the initial symptom was 12.5%, 22.5%, and 42.7%, respectively

Back to article page

Orphanet Journal of Rare Diseases

ISSN: 1750-1172